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Identity 
Other names: FLJ58702; NS5ATP9; OEATC-1; 
OEATC1; PAF; p15(PAF); p15PAF 




Murine gene embryonic expression shows highly 
restricted expression of KIAA0101 in facial 
prominences, limbs, somites, brain, spinal cord and hair 
follicles. It has a suggested role in embryonic 
development (van Beuren et al., 2007). 
Description 
The gene is composed of 4 exons. 
Transcription 
One transcript. RNA was expressed as a 1.1 kb 
message in liver, pancreas and placenta at high levels 
(Yu et al., 2001). RNA profiling shows it is highly 
expressed in a number of tumors, specifically in 
esophageal tumors, anaplastic thyroid carcinomas, 
pancreatic cancer and non-small-cell lung cancer lines 
(Yu et al., 2001;  
Hosokawa et al., 2007). KIAA0101 was also reported 
to be down-regulated in colon cancer cells (Simpson et 
al., 2006) and human hepatocellular carcinoma (Guo et 
al., 2006). Nuclear protein NF-kappaB (p50) (Li et al., 
2008), the Hepatitis C virus protein non-structural 
protein 5A (NS5A) (Shi et al., 2008) and ATF3 (Turchi 
et al., 2009) bind to the promoter region upstream of 
the KIAA0101 transcription initiation site promoting 





NS5ATP9, Hepatitis C virus NS5A-transactivated 
protein 9, HCV NS5A-transactivated protein 9, 
Overexpressed in anaplastic thyroid carcinoma-1, 
OEATC-1, OEATC1, p15(PAF), L5. 
Description 
The KIAA0101 gene encodes for a 111 amino acid 15 
kDa protein. It contains a conserved proliferating cell 




DNA diagram. KIAA0101 9768 chr: 62444265-62460755. One transcript, 4 exons. 
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Predominant expression in liver, pancreas and brain. 
Not detected in heart or liver (Yu et al., 2001). The 
KIAA0101 protein was down-regulated in human 
hepatocellular carcinoma (Guo et al., 2006; Yuan et al., 
2007). Increased protein levels have been detected in 
pancreatic cancer cells (Hosokawa et al., 2007). 
Localisation 
Nucleus, mitochondrion (Yu et al., 2001; Guo et al., 
2006; Simpson et al., 2006; Yuan et al., 2007). 
Function 
The KIAA0101 protein binds to PCNA through a 
conserved PCNA binding domain. PCNA is required 
for DNA replication or repair as a supplementary factor 
for DNA polymerase (Paunesku et al., 2001). Proteins 
bound to PCNA can prevent its binding to DNA 
polymerase, in turn leading to inhibition of DNA 
synthesis, cell cycle progression and G1 cell cycle 
arrest (Yuan et al., 2007). PCNA binding proteins also 
interact with each other to modulate this regulation. For 
example, KIAA0101 also interacts in a complex with 
p33ING1 isoform 2, another PCNA binding protein 
which is a potential tumor suppressor and regulator of 
p53 (Simpson et al., 2006). UV irradiation caused 
increased association of KIAA0101 with PCNA 
suggesting that this association occurs in response to 
DNA damage. KIAA0101 also competes with 
p21WAF for binding to PCNA (Yu et al., 2001). 
KIAA0101 most recently been shown to act in concert 
with ATF3 to control genomic integrity after UV stress 
(Turchi et al., 2009). KIAA0101 expression levels are 
also regulated by NF-kappaB, this protein family 
having significant roles in apoptosis, cell cycle 
regulation and onocgenesis (Hosokawa et al., 2007; Li 
et al., 2008). Together this data suggests a likely role 
for KIAA0101 in DNA repair and in protection from 
UV-induced cell death. 
Mutations 
Note 
Experimentally mutation I-A at position 65 and F-A at 
position 68 result in loss of PCNA binding (Yu et al., 
2001). No other mutations have been described. 
Screening of colon tumour samples identified a 
polymorphism in the intronic region just prior to the 





KIAA0101 expression was proposed to promote 
growth advantage and hypoxic insult resistance and be 
associated with promoting cell proliferation (Yuan et 
al., 2007). KIAA0101 overexpression was associated 
with concomitant p53 mutation and vascular invasion 
(Yuan et al., 2007). This study suggested that high 
expression in hepatocellular carcinoma was indicative 
of tumour recurrence, metastatic potential and poor 
prognosis (Yuan et al., 2007). KIAA0101 was also 
reported to be downregulated in hepatocellular 
carcinoma (Guo et al., 2006). This study suggested that 
KIAA0101 had a growth inhibitory effect. 
Astrocytomas 
Disease 
Grade IV (glioblastoma multiforme) astrocytomas had 
5 times higher expression levels when compared to 
Grade I (pilocytic) astrocyomas suggesting that 
KIAA0101 abundance correlates with malignancy 
grade in human astrocytes (Marie et al., 2008). 
Pancreatic cancer 
Disease 
Pancreatic cells overexpress KIAA0101 both at cDNA 
and protein level. Knock down of KIAA0101 by 
siRNA attenuated proliferation and DNA replication 
whereas overexpression enhanced cell growth in 
pancreatic cancer cell lines (Hosokawa et al., 2007). 
Anaplastic thyroid carcinoma 
Disease 
Anaplastic thyroid carcinoma cell lines had significant 
overexpression of KIAA0101. Cell growth was 
inhibited by silencing KIAA0101 expression using 
siRNA. KIAA0101 may be oncogenic or cell growth-
promoting but the mechanism for this is not understood 
(Mizutani et al., 2005). 
Follicular lymphoma 
Disease 
High expression of KIAA0101 (along with CCNB1 
(cyclin B1), CDC2, CDKN3A, CKS1B, ANP32E) was 
associated with better survival/response rate in a 
univariate analysis following CHOP 
(cyclophosphamide, vincristine, doxorubicin,  
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prednisone) chemotherapy for follicular lymphoma 
treatment. Identification of these proteins aims to 
develop a follicular lymphoma international prognostic 
index to aid in informing a successful treatment 
strategy (Bjorck et al., 2005). 
Oncogenesis 
This gene is thought to be oncogenic through 
modulation of DNA repair pathways via interaction 
with PCNA. 
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